Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone | ClinicalTrials.gov NCT06261619

ClinicalTrials.gov record NCT06261619, Sotair superiority trial, status completed

ClinicalTrials.govNCT06261619CompletedPublished 2026

Registry Record

View on ClinicalTrials.gov · NCT06261619 →Read our summary of the paper →

Study at a Glance

  • Registered title: Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone
  • Sponsor: Rhode Island Hospital
  • Population: Adults having non-emergent surgery under general anesthesia
  • Registry status: Completed

Results

Results are published in Resuscitation Plus (2026, journal pre-proof). Read the full article or read our summary.

Details are shown as listed on ClinicalTrials.gov (last update posted 2026-07-21). See the registry record for the current status.

Sotair® is FDA 510(k) cleared (K212905) for use in non-breathing adults and is intended to minimize gastric inflation during manual ventilation. Refer to the Instructions for Use for indications, contraindications, warnings and precautions. SotairIQ™ is for training and education use only. This page lists a registered study for healthcare professionals. The registry record is the authoritative source for study details.